Search results for: 'basics'

Your search '2day basics nj 2020' did not match any products.
Showing results using some of your search terms '2day basics nj 2020 '.

8 Item(s)

Show per page
  • FOR IMMEDIATE RELEASE:   Blonder Tongue Reports Fourth Quarter and Year End 2019 Results OLD BRIDGE, NJ / April 9, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the fourth quarter and year ended December 31, 2019. Net sales decreased $396,000 or 7.3% to $5,045,000 for the fourth quarter of 2019 from $5,441,000 for the comparable period in 2018.  Net loss for the three months ended December 31, 2019 was $(3,842,000) or $(0.41) per share, compared ...
  • Blonder Tongue Reports First Quarter 2020 Results OLD BRIDGE, NJ / May 15, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the first quarter ended March 31, 2020. Net sales decreased $32,000 or 0.8% to $4,050,000 for the first quarter of 2020 from $4,082,000 for the comparable period in 2019.  Net loss for the three months ended March 31, 2020 was $(2,080,000) or $(0.21) per diluted share, compared to net earnings of $5,325,000 or $0.53 per diluted shar...
  • Blonder Tongue Reports Second Quarter 2020 Results OLD BRIDGE, NJ / August 7, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the second quarter and six months ended June 30, 2020. Net sales decreased $1,606,000 or 29.5% to $3,831,000 for the second quarter of 2020 from $5,437,000 for the comparable period in 2019.  Net loss for the three months ended June 30, 2020 was $(1,194,000) or $(0.12) per diluted share, compared to $(891,000) or $(0.09) per dilu...
  • Blonder Tongue Reports Third Quarter 2020 Results OLD BRIDGE, NJ / November 11, 2020 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the third quarter and nine months ended September 30, 2020. Net sales decreased $1,107,000 or 21.0% to $4,171,000 for the third quarter of 2020 from $5,278,000 for the comparable period in 2019.  Net loss for the three months ended September 30, 2020 was $(1,787,000) or $(0.18) per diluted share, compared to $(1,334,000) or $(0...
  • OLD BRIDGE, NJ / March 12, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the fourth quarter and year ended December 31, 2020. Commenting on the year end and fourth quarter results, Chief Executive Officer Ted Grauch noted, “Faced with a very difficult pandemic affected marketplace in 2020, the Company focused the year on completing a number of major organizational changes, R&D and intellectual property (IP) investments, product development, and in...
  • OLD BRIDGE, NJ / May 13, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the first quarter ended March 31, 2021. Blonder Tongue Laboratories, Inc. net sales decreased $799,000 or 19.7% to $3,251,000 for the first quarter of 2021 from $4,050,000 for the comparable period in 2020. Net loss for the three months ended March 31, 2021 was $(414,000) or $(0.04) per share, compared to $(2,080,000) or $(0.21) per share for the comparable period in 2020. Net cash p...
  • OLD BRIDGE, NJ / August 12, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the second quarter and six months ended June 30, 2021. Blonder Tongue Laboratories, Inc. net sales increased $507,000 or 13.2% to $4,338,000 for the second quarter of 2021 from $3,831,000 for the comparable period in 2020. Net income for the three months ended June 30, 2021, was $1,626,000 or $0.11 per diluted share, compared to a net loss of $(1,194,000) or $(0.12) per diluted ...
  • OLD BRIDGE, NJ / October 22, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR) announced its sales and results for the third quarter and nine months ended September 30, 2021. Blonder Tongue Laboratories, Inc. net sales increased $1,000 or 0.02% to $4,172,000 for the third quarter of 2021 from $4,171,000 for the comparable period in 2020. Net loss for the three months ended September 30, 2021, was $(201,000) or $(0.02) per diluted share, compared to a net loss of $(1,787,000) or $(0.18) per di...

8 Item(s)

Show per page